首页> 外文期刊>Environmental sciences Europe >Humanarzneimittel im aquatischen ?kosystem
【24h】

Humanarzneimittel im aquatischen ?kosystem

机译:人类在水生生态系统中使用的药品

获取原文
           

摘要

Goal In the Brandenburg State Office for the Environment an approach to assess the potential risk of drug residues in aquatic ecosystems has been developed based on an investigation of the consumption amounts in 1999 to identify or to exclude a potential environmental risk of important human drugs and further to define priority substances for monitoring programs in Brandenburg in the future. Method This assessment approach tested with 60 drug agents is based on an exposure estimation considering the main path for the entry human—waste water—sewage plant—surface water, on a substance specific analysis of effects and on an analysis of the environmental fate as compartment distribution, bioaccumulation and persistence. Results In Brandenburg surface waters the drug agent concentration for eight of the considered substances is supposed to be greater than 1 μg/l and for at least 13 of the considered substanoes the PNEC in aquatic ecosystems is assumed to be lower than 1 μg/l. A potential risk for the environment can be seen for the antibiotics Ciprofloxacin-HCl and Clarithromycin, the disinfectants Benzalkonium Chloride, Cocospropylendiaminguaniacetat, Glucoprotamine, Laurylpropylenediamine and Polyvidone-iodine, the sexual hormon Ethinylestradiol, the antidiabetic Metformin-HCl, the antiepileptic Carbamazepine and the lipid regulator Clofibrinic acid on the basis of effects because their PEC:PNEC-relation is about 1 or higher. For further 19 drug agents an environmental risk is to be assumed because of their environmental behaviour without support by ecotoxicological data at present. Conclusion Although there is only a small base of valid ecotoxicological data, this risk assessment shows that adverse effects in the aquatic environment by some drug agents cannot be excluded. However, it should be noted that this first assessment gives only a crude orientation. Appropriate test data are necessary to refine the assessment in future.
机译:目标在勃兰登堡州环境办公室,根据对1999年消费量的调查,开发了一种方法来评估水生生态系统中药物残留的潜在风险,以识别或排除重要人类药物和其他药物的潜在环境风险。为将来在勃兰登堡州的监测计划定义优先物质。方法用60种药物进行测试的评估方法是基于暴露估计,其中考虑了进入人体的主要途径(废水,污水处理厂,地表水),对物质的具体影响分析以及对作为隔室的环境命运的分析分布,生物蓄积和持久性。结果在勃兰登堡地表水中,认为其中八种所考虑物质的药物浓度均大于1μg/ l,而对于至少13种所认为的物质,水生生态系统中的PNEC均低于1μg/ l。抗生素环丙沙星盐酸盐和克拉霉素,苯扎氯铵消毒剂,椰油酰胺丙基氨胺胍消毒剂,葡萄糖胺,月桂基丙二胺和聚维酮碘,性激素乙炔雌二醇,抗糖尿病药二甲双胍-盐酸调节剂纤维蛋白酸是基于作用的,因为它们的PEC:PNEC关系约为1或更高。对于另外的19种药物,由于目前的环境行为而没有生态毒理学数据的支持,因此将承担环境风险。结论尽管只有很少的有效生态毒理学数据,但该风险评估表明不能排除某些药物对水生环境的不利影响。但是,应该注意的是,该第一次评估仅给出了一个粗略的方向。将来需要适当的测试数据来完善评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号